FOXJ2 and autoimmune polyendocrinopathy: Specifically, the enhanced H3K4me3 peak and chromatin accessibility at the FOXJ2 promoter were closely aligned with increased FOXJ2 transcription in patients with PAPS, as well as in an in vivo mouse model and an in vitro monocyte model mimicking APS.